Logo image of ALR

ALERISLIFE INC (ALR) Stock Fundamental Analysis

NASDAQ:ALR - Nasdaq - US33832D2053 - Common Stock - Currency: USD

1.32  +0.01 (+0.76%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALR. ALR was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of ALR have multiple concerns. ALR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALR has reported negative net income.
In the past year ALR has reported a negative cash flow from operations.
ALR Yearly Net Income VS EBIT VS OCF VS FCFALR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 50M -50M -100M

1.2 Ratios

ALR has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALR Yearly ROA, ROE, ROICALR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

1.3 Margins

ALR's Gross Margin of 17.07% is on the low side compared to the rest of the industry. ALR is outperformed by 67.54% of its industry peers.
ALR's Gross Margin has declined in the last couple of years.
ALR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.79%
GM growth 5Y-27.35%
ALR Yearly Profit, Operating, Gross MarginsALR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

ALR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALR has been increased compared to 1 year ago.
ALR has a worse debt/assets ratio than last year.
ALR Yearly Shares OutstandingALR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
ALR Yearly Total Debt VS Total AssetsALR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.82, we must say that ALR is in the distress zone and has some risk of bankruptcy.
ALR has a Altman-Z score (0.82) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.45 indicates that ALR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.45, ALR is in the better half of the industry, outperforming 64.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 0.82
ROIC/WACCN/A
WACC7.46%
ALR Yearly LT Debt VS Equity VS FCFALR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 1.58 indicates that ALR should not have too much problems paying its short term obligations.
ALR's Current ratio of 1.58 is fine compared to the rest of the industry. ALR outperforms 62.28% of its industry peers.
A Quick Ratio of 1.58 indicates that ALR should not have too much problems paying its short term obligations.
ALR's Quick ratio of 1.58 is fine compared to the rest of the industry. ALR outperforms 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
ALR Yearly Current Assets VS Current LiabilitesALR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

ALR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.67%.
Looking at the last year, ALR shows a very negative growth in Revenue. The Revenue has decreased by -31.89% in the last year.
Measured over the past years, ALR shows a decrease in Revenue. The Revenue has been decreasing by -7.47% on average per year.
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.73%
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-12.4%
Revenue growth 5Y-7.47%
Sales Q2Q%-19.12%

3.2 Future

ALR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.52% yearly.
The Revenue is expected to decrease by -1.08% on average over the next years.
EPS Next Y-29.68%
EPS Next 2Y15.18%
EPS Next 3Y20.52%
EPS Next 5YN/A
Revenue Next Year-23.66%
Revenue Next 2Y-6.24%
Revenue Next 3Y-1.08%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALR Yearly Revenue VS EstimatesALR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
ALR Yearly EPS VS EstimatesALR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 -1 -2 -3 -4 -5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALR Price Earnings VS Forward Price EarningsALR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALR Per share dataALR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

ALR's earnings are expected to grow with 20.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.18%
EPS Next 3Y20.52%

More info and screens

0

5. Dividend

5.1 Amount

ALR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALERISLIFE INC

NASDAQ:ALR (3/17/2023, 8:00:00 PM)

1.32

+0.01 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-07 2023-03-07
Earnings (Next)05-01 2023-05-01
Inst Owners89.33%
Inst Owner ChangeN/A
Ins Owners2.94%
Ins Owner Change0%
Market Cap44.18M
Analysts45
Price Target1.53 (15.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.36%
Min EPS beat(2)-40.7%
Max EPS beat(2)-32.01%
EPS beat(4)0
Avg EPS beat(4)-99.82%
Min EPS beat(4)-179.03%
Max EPS beat(4)-32.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-5.43%
Max Revenue beat(2)-0.24%
Revenue beat(4)0
Avg Revenue beat(4)-4.43%
Min Revenue beat(4)-7.44%
Max Revenue beat(4)-0.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-2.07
FCFYN/A
OCF(TTM)-1.61
OCFYN/A
SpS21.15
BVpS4.61
TBVpS4.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.07%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.79%
GM growth 5Y-27.35%
F-Score2
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 122.36%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 0.82
F-Score2
WACC7.46%
ROIC/WACCN/A
Cap/Depr(3y)158.12%
Cap/Depr(5y)159.36%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.73%
EPS Next Y-29.68%
EPS Next 2Y15.18%
EPS Next 3Y20.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-12.4%
Revenue growth 5Y-7.47%
Sales Q2Q%-19.12%
Revenue Next Year-23.66%
Revenue Next 2Y-6.24%
Revenue Next 3Y-1.08%
Revenue Next 5YN/A
EBIT growth 1Y-736.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.21%
EBIT Next 3Y35.15%
EBIT Next 5YN/A
FCF growth 1Y-137.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.74%
OCF growth 3YN/A
OCF growth 5YN/A